|
π
|
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
74 auth.
G. Goodwin,
S. Aaronson,
Oscar Alvarez,
Peter C Arden,
Annie Baker,
J. Bennett,
Catherine I V Bird,
R. Blom,
C. Brennan,
Donna Brusch,
L. Burke,
Kete Campbell-Coker,
Robin Carhart-Harris,
Joseph Cattell,
A. Daniel,
...
C. Debattista,
B. Dunlop,
Katherine Eisen,
D. Feifel,
MacKenzie Forbes,
Hannah M Haumann,
D. Hellerstein,
Astrid I Hoppe,
M. Husain,
L. Jelen,
J. Kamphuis,
Julie Kawasaki,
John R. Kelly,
Richard E Key,
R. Kishon,
Stephanie Knatz Peck,
Gemma Knight,
Martijn H B Koolen,
M. Lean,
R. Licht,
J. Maples-Keller,
J. Mars,
L. Marwood,
M. McElhiney,
Tammy Miller,
Arvin Mirow,
S. Mistry,
Tanja Mletzko-Crowe,
Liam N Modlin,
R. Nielsen,
Elizabeth M. Nielson,
S. R. Offerhaus,
V. OβKeane,
T. PΓ‘lenΓΔek,
D. Printz,
Marleen C. Rademaker,
Aumer van Reemst,
Frederick Reinholdt,
D. Repantis,
J. Rucker,
Samuel Rudow,
S. Ruffell,
A. Rush,
R. Schoevers,
Mathieu Seynaeve,
Samantha Shao,
J. Soares,
M. Somers,
S. Stansfield,
Diane Sterling,
Aaron Strockis,
J. Tsai,
L. Visser,
M. Wahba,
S. Williams,
A. Young,
Paula Ywema,
S. Zisook,
E. Malievskaia
|
8 |
2022 |
8
π
|
|
π
|
International online survey of 1048 individuals with functional neurological disorder
12 auth.
M. Butler,
Oliver Shipston-Sharman,
Mathieu Seynaeve,
Jianan Bao,
S. Pick,
Abigail Bradley-Westguard,
...
Eveliina Ilola,
Bridget Mildon,
Dawn Golder,
J. Rucker,
J. Stone,
T. Nicholson
|
5 |
2021 |
5
π
|
|
π
|
Psychedelic treatment of functional neurological disorder: a systematic review
8 auth.
M. Butler,
Mathieu Seynaeve,
T. Nicholson,
S. Pick,
R. Kanaan,
A. Lees,
...
A. Young,
J. Rucker
|
4 |
2020 |
4
π
|
|
π¬
|
Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders.
Fiona Harding,
Mathieu Seynaeve,
J. Keeler,
H. Himmerich,
J. Treasure,
C. Kan
|
3 |
2021 |
3
π¬
|
|
π
|
Clinical factors associated with progression to dementia in people with late-life depression: a cohort study of patients in secondary care
7 auth.
Georgia Peakman,
N. Karunatilake,
Mathieu Seynaeve,
G. Perera,
D. Aarsland,
R. Stewart,
...
C. Mueller
|
3 |
2020 |
3
π
|
|
π
|
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants
9 auth.
J. Rucker,
C. Roberts,
Mathieu Seynaeve,
Allan H Young,
B. Suttle,
Takahiro Yamamoto,
...
A.O. Ermakova,
Fiona Dunbar,
F. Wiegand
|
2 |
2024 |
2
π
|
|
π
|
Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results.
9 auth.
M. Butler,
Mathieu Seynaeve,
Abigail Bradley-Westguard,
Jianan Bao,
A. Crawshaw,
S. Pick,
...
M. Edwards,
T. Nicholson,
J. Rucker
|
1 |
2022 |
1
π
|
|
π
|
105. Intranasal 5-MeO-DMT: Safety, PK and Effect on Altered States of Consciousness in Healthy Volunteers
9 auth.
J. Rucker,
Mathieu Seynaeve,
A. Young,
Claire L. Roberts,
B. Suttle,
Takahiro Yamamoto,
...
A. Ermakova,
F. Dunbar,
F. Wiegand
|
0 |
2023 |
0
π
|
